Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.

Richard Head elected Associate Member to the EphMRA Board

Richard Head elected Associate Member to the EphMRA Board

We are pleased to announce that Director Richard Head has been re-elected to the EphMRA Executive Board 2015 following a vote by other Associate Members.

Richard has 11 years’ experience in international market research, covering qualitative and quantitative across a variety of therapy areas. He is championing innovation at Research Partnership, and in his time as board member, Richard has been an active voice for Associate Members. The board, which includes both pharmaceutical company and supplier side representation, helps to determine where EphMRA should focus in order to best benefit its members.For 2015-17, Richard aims to advance his existing efforts, and commented, “I am delighted to continue to represent all Associate Members, from full service agencies to syndicated data suppliers and fieldwork providers, on the EphMRA board. I am passionate about maintaining the highest standards in market research, as expected from EphMRA, advocating the use of innovative technologies and solutions. I look forward to working with my fellow board members to advance EphMRA’s strategic goals.” Thank you to everyone that voted and congratulations to Richard on his reappointment.
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »

  • Posted by Julie Denny
  • June 18, 2015
  • News

Will Tolley promoted to Associate Director

Will Tolley promoted to Associate Director

We are delighted to announce the promotion of Will Tolley to Associate Director.

Will has over nine years of healthcare market research experience, having previously been employed as Insight Manager for the healthcare team at Millward Brown.Will is part of a large team of specialist quantitative directors and project managers working across all our six global offices.
Commentating on his promotion, Quantitative Director Karen Swords, said, “Will’s promotion is integral to our objective of continuing to expand our quantitative services, particularly in our key areas of expertise – advanced analytics such as segmentation or demand assessments and brand tracking."

read more »

  • Posted by Rachel Howard
  • June 12, 2015
  • Articles

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

If left untreated, hepatitis C leads to chronic health problems putting a huge strain on national healthcare resources.
During the course of my working life, hepatitis C is one of the therapy areas in which I have seen the most dramatic advances in terms of treatment.  It is definitely one of pharma’s success stories. It has experienced rapid evolution from interferon- and ribavirin-based treatment in 1998, through pegylated interferon-based regimens and protease inhibitors and on to the recent wave of direct-acting antiviral therapies available today. It would not be an exaggeration to say that these interferon-free treatment regimens, with high efficacy (Sustained Virological Response (SVR) rates approaching 100%), minimal side effects and short treatment durations, have the potential to revolutionize the treatment of hepatitis C.

read more »

HCV LATAM infographic

HCV LATAM infographic

Hepatitis C virus (HCV) is well recognised as a worldwide problem with approximately 150 million chronic carriers. If left untreated HCV becomes a chronic health problem putting a huge strain on national healthcare resources. Within Latin America studies suggest that around 4.6 million people are currently infected with chronic HCV.
Click here to view our latest infographic, in which we provide an introduction to the HCV LATAM patient.
Find out more about our experience in emerging markets »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »

  • Posted by Julie Denny
  • June 5, 2015
  • Articles

Presenting the power of visual storytelling

Presenting the power of visual storytelling

Communicating research insights is a major focus for today’s market researcher, particularly in the global healthcare environment.

It’s not enough now to present the research evidence. We must tell the story, using a clear narrative that can engage a broad and often disparate group of stakeholders. The digital revolution has not only increased the speed and form in which we can collect, disseminate and receive information, it also offers us exciting new ways of presenting the insights. We invited our in-house Graphic Designer Amanda Brent to tell us about the range of visualisation tools available and explain how these can be used to deliver enhanced market research deliverables.
Q: How can visual storytelling add value to a healthcare market research project?A: Visual storytelling can really help communicate complex information in an accessible and engaging way. Whilst the market research client will still require a report of the complete findings from a study, they also need a means of sharing just the key insights with their marketing team and other stakeholders. By creating, for example, an animated video or infographic they can condense a report into the critical information that their audience requires. By making the outputs visual it’s easier for the audience to engage, comprehend and understand the story being communicated.

read more »